美国 · SEC FORM 4
Edwards Lifesciences Corp
EW · NYSE · CIK 0001099800 · Healthcare · Medical Devices
内部人信号
0 qualifying P purchase groups
当前 180 天评分窗口
97 同一窗口内观察到的 Form 4 交易行
26 sales · 71 期权、代扣税、授予、赠与或其他交易行
为什么没有活跃信号？
评分构成
活跃窗口内没有合资格买入，因此不计算分数。缺失的输入不会被当作零分或看空信号。
为什么没有分数？
- 没有合资格公开市场买入可提供聚集度、规模、角色、近期性或确信度输入。
- 卖出及其他 Form 4 活动继续作为背景显示，不会形成负分。
卖出和其他 Form 4 活动会单独显示，不会形成负面买入信号。没有买入不会被评分为看空。
内部人活动时间轴
申报人轨道展示最近 180 天。符号形状区分交易类型；卖出仅作为背景。
Showing the six most active owners; 2 additional owner(s) remain in Form 4 申报证据.
买方广度、集中度与聚集买入
合资格买入进入 180 天研究窗口后，这些模块才会启用。
信号历史
Scores are archived only when the company qualifies for a published US buy-signal snapshot. 最近一次合资格买入: 2024-05-06 · Zovighian Bernard J.
近期 Form 4 活动
P is an open-market or private purchase. S is a sale. M, F, A and G usually describe exercises, tax withholding, awards and gifts. These categories remain visually separate.
市场背景
该股票尚未获取市场背景。每日任务会轮转处理美国股票池。
空头余额
空头余额是券商向 FINRA 申报的外部背景数据，不影响内部人信号。
- 空头股数
- 9,538,735
- 上期报告
- 9,088,401
- 日均成交量
- 3,875,387
- 回补天数
- 2.5
FINRA 结算日：2026-09-30 · 获取日期 2026-10-12 · FINRA 股票空头余额 ↗. 这是股数，每月两个结算日之后约一周公布；不是占已发行股份的比例。
历史股票买入
Qualifying code P transactions in the local Form 4 history, including purchases outside the current signal window.
Form 4 申报证据
150 transaction lines in the latest 365-day window; 1,420 in local history.
| 日期 | 申报人 | 类型 | 证券 | 股数 | 平均价格 | 估算金额 | 来源 |
|---|---|---|---|---|---|---|---|
| 2026-10-08 | Lippis Daniel J. | 卖出 (S) | Common Stock | 619 | USD 85.65 | USD 53,017 | SEC 申报 ↗ |
| 2026-10-08 | Lippis Daniel J. | 期权行权／转换 (M) | Common Stock | 619 | USD 72.68 | USD 44,989 | SEC 申报 ↗ |
| 2026-09-14 | Markowitz Wayne | 代扣税 (F) | Common Stock | 568 | USD 84.37 | USD 47,922 | SEC 申报 ↗ |
展开近期 Form 4 证据 (30 grouped rows)
| 日期 | 申报人 | 类型 | 证券 | 股数 | 平均价格 | 估算金额 | 来源 |
|---|---|---|---|---|---|---|---|
| 2026-10-08 | Lippis Daniel J. | 卖出 (S) | Common Stock | 619 | USD 85.65 | USD 53,017 | SEC 申报 ↗ |
| 2026-10-08 | Lippis Daniel J. | 期权行权／转换 (M) | Common Stock | 619 | USD 72.68 | USD 44,989 | SEC 申报 ↗ |
| 2026-09-14 | Markowitz Wayne | 代扣税 (F) | Common Stock | 568 | USD 84.37 | USD 47,922 | SEC 申报 ↗ |
| 2026-09-13 | Dahl Andrew M. | 代扣税 (F) | Common Stock | 253 | USD 84.37 | USD 21,346 | SEC 申报 ↗ |
| 2026-09-11 | Markowitz Wayne | 代扣税 (F) | Common Stock | 355 | USD 86.77 | USD 30,803 | SEC 申报 ↗ |
| 2026-09-11 | Lippis Daniel J. | 卖出 (S) | Common Stock | 619 | USD 87.51 | USD 54,169 | SEC 申报 ↗ |
| 2026-09-11 | Lippis Daniel J. | 期权行权／转换 (M) | Common Stock | 619 | USD 72.68 | USD 44,989 | SEC 申报 ↗ |
| 2026-09-11 | Chopra Daveen | 代扣税 (F) | Common Stock | 398 | USD 86.77 | USD 34,534 | SEC 申报 ↗ |
| 2026-08-31 | Dahl Andrew M. | 卖出 (S) | Common Stock | 544 | USD 91.06 | USD 49,537 | SEC 申报 ↗ |
| 2026-08-28 | Bruls Annette | 卖出 (S) | Common Stock | 2,644 | USD 89.98 | USD 237,907 | SEC 申报 ↗ |
| 2026-08-26 | Markowitz Wayne | 卖出 (S) | Common Stock | 1,240 | USD 91.47 | USD 113,423 | SEC 申报 ↗ |
| 2026-08-26 | Chopra Daveen | 卖出 (S) | Common Stock | 31,800 | USD 91.02 | USD 2,894,371 | SEC 申报 ↗ |
| 2026-08-26 | Chopra Daveen | 期权行权／转换 (M) | Common Stock | 31,800 | USD 72.68 | USD 2,311,224 | SEC 申报 ↗ |
| 2026-08-11 | Lippis Daniel J. | 卖出 (S) | Common Stock | 619 | USD 92.03 | USD 56,967 | SEC 申报 ↗ |
| 2026-08-11 | Lippis Daniel J. | 期权行权／转换 (M) | Common Stock | 619 | USD 72.68 | USD 44,989 | SEC 申报 ↗ |
| 2026-07-30 | Markowitz Wayne | 卖出 (S) | Common Stock | 146 | USD 86.03 | USD 12,587 | SEC 申报 ↗ |
| 2026-07-28 | Markowitz Wayne | 卖出 (S) | Common Stock | 9,628 | USD 85.06 | USD 818,958 | SEC 申报 ↗ |
| 2026-07-28 | Markowitz Wayne | 期权行权／转换 (M) | Common Stock | 9,628 | USD 74.02 | USD 712,665 | SEC 申报 ↗ |
| 2026-07-27 | Zovighian Bernard J | 卖出 (S) | Common Stock | 2,921 | USD 83.93 | USD 245,122 | SEC 申报 ↗ |
| 2026-07-27 | Zovighian Bernard J | 赠与 (G) | Common Stock | 320 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-07-11 | Bruls Annette | 代扣税 (F) | Common Stock | 109 | USD 92.21 | USD 10,051 | SEC 申报 ↗ |
| 2026-07-10 | Lippis Daniel J. | 卖出 (S) | Common Stock | 619 | USD 91.70 | USD 56,762 | SEC 申报 ↗ |
| 2026-07-10 | Lippis Daniel J. | 期权行权／转换 (M) | Common Stock | 619 | USD 72.68 | USD 44,989 | SEC 申报 ↗ |
| 2026-07-09 | Mistras Theodora | 奖励／授予 (A) | Common Stock | 99,920 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-07-07 | Lippis Daniel J. | 代扣税 (F) | Common Stock | 377 | USD 95.18 | USD 35,883 | SEC 申报 ↗ |
| 2026-06-30 | Lippis Daniel J. | 卖出 (S) | Common Stock | 619 | USD 91.40 | USD 56,577 | SEC 申报 ↗ |
| 2026-06-30 | Lippis Daniel J. | 期权行权／转换 (M) | Common Stock | 619 | USD 72.68 | USD 44,989 | SEC 申报 ↗ |
| 2026-06-17 | Zovighian Bernard J | 卖出 (S) | Common Stock | 523 | USD 87.92 | USD 45,982 | SEC 申报 ↗ |
| 2026-05-29 | Dahl Andrew M. | 卖出 (S) | Common Stock | 568 | USD 86.08 | USD 48,853 | SEC 申报 ↗ |
| 2026-05-27 | BOBO DONALD E JR | 卖出 (S) | Common Stock | 23,145 | USD 86.42 | USD 2,000,191 | SEC 申报 ↗ |
Multiple price lines in one filing are grouped and share-weighted. Price and value are blank when a grouped filing line lacks price evidence.
快照与身份
| 快照日期 | 2026-10-18 |
|---|---|
| 排名版本 | US-v1.2 |
| 数据质量 | PASS ELIGIBLE · — |
| 股票代码 | EW |
| CIK | 0001099800 |
| 行业 | Healthcare |
| 细分行业 | Medical Devices Yahoo Finance |
| SEC SIC | 3842 Orthopedic, Prosthetic & Surgical Appliances & Supplies |
| 交易所 | NYSE |
数据覆盖
| 本地 Form 4 历史 | 1,420 transaction lines from 2020-01-02 to 2026-10-08 2 P purchase lines · 585 S sale lines · 833 other lines |
|---|---|
| SEC 公司申报 | 打开 SEC 申报 ↗ |
Local ledger as of 2026-10-18. Mapping status is an audit field and does not erase SEC filing evidence.